Impact of Seasonal Nirsevimab Administration in Infants Born During the RSV Circulation Period on RSV-Related Hospitalizations: A Population-Based Study from Emilia-Romagna, Northern Italy
Seasonal administration of nirsevimab to infants born during the RSV circulation period was associated with a marked and sustained reduction in RSV-related hospitalizations in early infancy. These findings support the effectiveness of targeted, seasonally timed infant immunoprophylaxis as a population-level RSV prevention strategy.
Authors
- Maria Elena Capra (ORCID: https://orcid.org/0000-0003-0848-5228)
- Battista Guidi
- Cristina Malaventura (ORCID: https://orcid.org/0000-0001-8517-4170)
- Agnese Suppiej (ORCID: https://orcid.org/0000-0001-5130-1450)
- Valentina Fainardi (ORCID: https://orcid.org/0000-0003-4601-7484)
- G. Maglietta
- Chiara Ghizzi
- Beatrice Rita Campana
- Francesca Alberghi
- Andrea Miceli
- Emanuele Filice
- Matteo Puntoni
- Melodie Olivia Aricò
- Marcello Stella
- Susanna Esposito
- Federico Marchetti
- Alessandro De Fanti
- Giacomo Biasucci
- Gianluca Vergine
Institutions
- University of Parma (IT)
- University of Ferrara (IT)
- Santa Maria Nuova Hospital (IT)
- Azienda Unità Sanitaria Locale Della Romagna (IT)
- Ospedale G.B. Morgagni - L.Pierantoni (IT)
- Ospedale Infermi di Rimini (IT)
- Villa Pineta Hospital (IT)
- Azienda-Unita' Sanitaria Locale Di Cesena (IT)
- Guglielmo da Saliceto Hospital (IT)
Publication Details
- Journal
- Vaccines
- Published
- 2026-02-14
- DOI
- https://doi.org/10.3390/vaccines14020182
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Parma